We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+13.86%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$224M
AUM Growth
+$18.5M
Cap. Flow
-$2.48M
Cap. Flow %
-1.11%
Top 10 Hldgs %
40.31%
Holding
44
New
1
Increased
11
Reduced
18
Closed
3

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$4.65M
2
PTON icon
Peloton Interactive
PTON
+$2.77M
3
EXE
Expand Energy Corp
EXE
+$2.18M
4
COF icon
Capital One
COF
+$1.26M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$1.09M

Top Sells

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$2.74M
2
SI
Silvergate Capital Corporation
SI
+$2.36M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.04M
4
FISV
Fiserv Inc
FISV
+$1.37M
5
OVV icon
Ovintiv
OVV
+$975K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.12%
2 Financials 20.01%
3 Energy 10.57%
4 Industrials 9.11%
5 Technology 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXPE icon
1
Expedia Group
EXPE
$37.3B
$12.7M 5.64%
130,600
-1,425
-1% -$149K
OMF icon
2
OneMain Financial
OMF
$7.43B
$11M 4.89%
296,100
+17,200
+6% +$691K
ET icon
3
Energy Transfer Partners
ET
$70B
$9.23M 4.11%
739,800
– –
META icon
4
Meta Platforms (Facebook)
META
$1.52T
$8.96M 3.99%
42,275
+2,100
+5% +$358K
BABA icon
5
Alibaba
BABA
$307B
$8.9M 3.97%
87,150
-1,225
-1% -$123K
AMZN icon
6
Amazon
AMZN
$3T
$8.44M 3.76%
81,700
+2,000
+3% +$193K
OVV icon
7
Ovintiv
OVV
$16.6B
$8.24M 3.67%
228,300
-22,100
-9% -$975K
MAT icon
8
Mattel
MAT
$4.2B
$8.16M 3.64%
443,500
+18,000
+4% +$334K
GOOS
9
Canada Goose Holdings
GOOS
$862M
$7.53M 3.36%
391,300
+17,600
+5% +$348K
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.36T
$7.39M 3.29%
71,200
– –
DAL icon
11
Delta Air Lines
DAL
$60B
$7.34M 3.27%
210,300
– –
C icon
12
Citigroup
C
$226B
$6.96M 3.1%
148,400
+12,600
+9% +$618K
TMHC
13
DELISTED
Taylor Morrison
TMHC
$6.8M 3.03%
177,675
-10,925
-6% -$384K
NCLH icon
14
Norwegian Cruise Line
NCLH
$8.83B
$6.65M 2.96%
494,600
-8,500
-2% -$127K
GM icon
15
General Motors
GM
$76.8B
$6.56M 2.92%
178,975
-3,725
-2% -$141K
UBER icon
16
Uber
UBER
$153B
$6.1M 2.72%
192,400
-27,800
-13% -$882K
FISV
17
Fiserv Inc
FISV
$27.7B
$6.04M 2.69%
53,425
-12,475
-19% -$1.37M
UAL icon
18
United Airlines
UAL
$41.7B
$5.94M 2.65%
134,300
-5,500
-4% -$264K
TEVA icon
19
Teva Pharmaceuticals
TEVA
$41.1B
$5.54M 2.47%
626,000
-206,575
-25% -$2.04M
JPM icon
20
JPMorgan Chase
JPM
$948B
$5.28M 2.35%
40,500
-5,000
-11% -$685K
SPLK
21
DELISTED
Splunk Inc
SPLK
$5.08M 2.26%
53,000
– –
TNL icon
22
Travel + Leisure Co
TNL
$4.69B
$4.99M 2.22%
127,300
– –
EXE
23
Expand Energy Corp
EXE
$21.5B
$4.9M 2.18%
64,500
+26,500
+70% +$2.18M
COIN icon
24
Coinbase
COIN
$40.3B
$4.87M 2.17%
72,100
-7,400
-9% -$443K
FTCH
25
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$4.85M 2.16%
986,800
-94,300
-9% -$512K
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Patient Capital Management held 44 positions worth $224M, up 9% from $206M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Patient Capital Management's Q1 2023 filing shows 1 new, 11 increased, 18 reduced and 3 closed positions. Its largest new stake was UBS Group: 222,800 shares worth $4.75M. The largest sale was DXC Technology, an estimated $2.74M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 32% a quarter earlier, followed by Financials and Energy.

  • Patient Capital Management's largest Q1 2023 buy was UBS Group: 222,800 shares worth $4.75M.
  • Patient Capital Management added most to Peloton Interactive in Q1 2023, an estimated $2.77M increase.
  • Patient Capital Management's biggest Q1 2023 reduction was DXC Technology, cutting an estimated $2.74M.
  • Patient Capital Management fully exited Silvergate Capital Corporation in Q1 2023, selling an estimated $2.36M.
  • Patient Capital Management's ten largest holdings make up 40% of its $224M portfolio in Q1 2023.
  • Patient Capital Management opened 1 new position and closed 3 in Q1 2023.
  • Patient Capital Management's portfolio value rose 9% quarter-over-quarter to $224M.

Based on Patient Capital Management's 13F filing for Q1 2023, filed 15 May 2023.